-
Mashup Score: 1NECTIN4 Amplifications as Genomic Predictors of EV Responses in Patients With mUC | GU Oncology Now - 16 hour(s) ago
In those who did not undergo EV treatment, NECTIN4 amplifications were not connected with outcomes.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4
A new study conducted by an international research team has identified new susceptibility regions that are associated with renal cell carcinoma development risk.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 12
Alison Birtle joins The Uromigos to provide an update on the POUT trial, which analyzed the use of adjuvant chemotherapy after nephroureterectomy for patients with UTUC.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Managing mUC With Pembrolizumab, Radical Resection of Primary Tumor | GU Oncology Now - 2 day(s) ago
A multi-institutional case study analyzed the outcomes of 4 patients with locally advanced or oligometastatic urothelial carcinoma with complete response on imaging.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6
Dr. Zakharia explains why guadecitabine plus durvalumab may be a good treatment approach in patients with advanced RCC.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
We spoke with several researchers involved in exploring the clinical utility of liquid biopsy for genitourinary cancers.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 4Evaluating Gemcitabine, Docetaxel Versus Bacillus Calmette-GuΓ©rin in Patients With UTUC | GU Oncology Now - 4 day(s) ago
The only guideline-recommended endoluminal treatment option for patients with HG UTUC is bacillus Calmette-GuΓ©rin.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3
Monika Joshi, MD, MRCP, of Penn State Cancer Institute, contextualizes the results of the THOR study within the treatment landscape for FGFR2/3-altered advan…
Source: www.youtube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Dr. Afari elaborates on the factors he identified that contribute to renal function improvement post-partial nephrectomy.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2New Noninvasive Urine Test Can Reduce Unnecessary Biopsies in Advanced Prostate Cancer | GU Oncology Now - 6 day(s) ago
A new 18-gene urine test developed by Dr. Jeffrey Tosoian and colleagues can improve PSA screening outcomes relative to existing biomarker tests in patients with high-grade PCa.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
π A study from @niklas_kluemper and colleagues sought to determine if #NECTIN4 amplifications can predict #EV response in patients with #mUC. π§ Find Out More: https://t.co/FVhoyJIlVO https://t.co/kYnJBRLt0b